Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Beyond Anecdotes: Measuring Global Health Impact in Washington State
|
Lisa Cohen |
11/18/09 |
Seattle
|
|
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/12/09 |
Seattle
|
|
ISB Nabs $8M for Cancer Genome
|
Luke Timmerman |
11/10/09 |
Seattle
|
|
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/05/09 |
Seattle
|
|
ISB Cuts Deal to Sequence 100 Genomes
|
Luke Timmerman |
11/02/09 |
Seattle
|
|
The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
Recruit Rock Star Scientists To Make Seattle Thrive as an Innovation Hub
|
Carl Weissman |
10/01/09 |
Seattle
|
|
Lee Hood’s New Idea, Integrative Diagnostics for Early Cancer Detection, Raises $7.5M
|
Luke Timmerman |
09/21/09 |
Seattle
|
|
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/17/09 |
Seattle
|
|
State Hands Out $5.1M Biotech Grants
|
Luke Timmerman |
09/15/09 |
Seattle
|
|
OVP Company Does 14 Genomes
|
Luke Timmerman |
09/09/09 |
Seattle
|
|
Can The Genome Be Cracked for $5,000? OVP, Enterprise Partners Say Yes in $45M Round
|
Luke Timmerman |
08/24/09 |
National
|
|
Clarus Leans on Customer Reviews at the Broad Institute to Bet on NanoString
|
Luke Timmerman |
07/29/09 |
Boston
|
|
NanoString Nabs $30M in Third Venture Round (Which It Hopes Will Be The Last)
|
Luke Timmerman |
06/09/09 |
Seattle
|
|
Genologics Aims to Turn Patient Records, Genome Data into Something Biologists Can Use
|
Luke Timmerman |
05/27/09 |
Seattle
|
|
The $1,000 Genome is Coming: How Will It Change the World?
|
Luke Timmerman |
05/21/09 |
Seattle
|
|
Accelerator’s New Startup, Xori, Aims to Use Chicken Cells to Make Better Antibody Drugs
|
Luke Timmerman |
05/14/09 |
Seattle
|
|
Gerry Langeler of OVP on Digital Energy and the Cyclical Nature of Venture Capital
|
Gregory T. Huang |
05/12/09 |
Seattle
|
|
Biotech Needs Charity, and Profit Motive, To Flourish
|
Richard Gayle |
05/11/09 |
Seattle
|
|
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/26/09 |
Seattle
|
|
Nanostring CEO Perry Fell Departs
|
Luke Timmerman |
03/24/09 |
Seattle
|
|
Leroy Hood, ISB Scientists Spot Genes For “Mad Cow” Disease; May Lead to Diagnostic Test
|
Luke Timmerman |
03/24/09 |
Seattle
|
|
Cell Therapeutics Nears Brink, ‘Hutch’ Dog Breed Test Hits Market, Lee Hood’s Institute Grows & More Seattle Area Life Sciences News
|
Luke Timmerman |
02/19/09 |
Seattle
|
|
Leroy Hood’s Institute Gains Momentum, Nine Years After Starting with “Crazy” Idea
|
Luke Timmerman |
02/13/09 |
Seattle
|
|
Hey, Don’t Forget the Puget Sound Life Sciences Universe!
|
Luke Timmerman |
02/09/09 |
Seattle
|
|
Sticking it to the VC Man: Johnny Stine Builds Biotech Startup on a Shoestring
|
Luke Timmerman |
02/06/09 |
Seattle
|
|
Procrastinating On Giving? A Last-Minute Guide to Seattle-Area Innovation Charities
|
Luke Timmerman |
12/30/08 |
Seattle
|
|
Vaccines Force Their Way off Pharma’s Back Burner, as Price Increases Help Fuel New Wave of Innovation
|
Luke Timmerman |
12/12/08 |
Seattle
|
|
Out With the Old Shots, In With the New: Xconomy Forum To Explore Disruptive Changes in Vaccines
|
Luke Timmerman |
12/05/08 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
